Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher Pearce currently holds 2,876,125 shares of Immune Therapeutics, Inc. (IMUN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Pearce has been a net neutral trader of IMUN stock. They have purchased $0 and sold $0 worth of shares.
Christopher Pearce's most recent insider trade was on Jul 18, 2016, when they sold 1,000,000 shares at $0.00 per share.
Christopher Pearce serves as Executive at Immune Therapeutics, Inc. (IMUN). They have executed 11 insider transactions totaling $0 over their tenure at the company.
Christopher Pearce holds the position of Executive at Immune Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Christopher Pearce has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Christopher Pearce was on Jul 18, 2016, when they sold $0 worth of IMUN shares. This transaction involved 1,000,000 shares at N/A per share.
Christopher Pearce currently owns 2,876,125 shares of Immune Therapeutics, Inc. (IMUN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher Pearce's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher Pearce has 11 Form 4 filings on record as an insider at Immune Therapeutics, Inc..
Set alerts for Christopher Pearce and 40,000+ other insiders.